Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how cognitive behavioral therapy for insomnia (CBT-I) can assist people with type 2 diabetes who struggle with sleep. The researchers aim to determine if better sleep can enhance diabetes control and overall health. Participants will either undergo an 8-week CBT-I program or continue their usual care. Ideal candidates have type 2 diabetes with recent poor blood sugar control (HbA1c over 7%) and significant sleep issues. This study seeks to determine if sleep therapy can be effectively integrated into regular diabetes care, especially in clinics serving high-risk populations.
As an unphased study, this trial provides a unique opportunity to contribute to innovative research that could enhance diabetes care for many.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Cognitive Behavioral Therapy for Insomnia is safe for individuals with type 2 diabetes?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) is a safe and effective treatment for individuals with insomnia. Studies have found that CBT-I can improve sleep and may also aid in managing diabetes by better controlling blood sugar levels. As CBT-I does not involve medications, there are no drug-related side effects.
Most individuals find the treatment manageable. It works by helping change sleep habits and patterns, leading to better sleep without the need for pills. Reports of negative effects are rare, making it a safe choice for those seeking to improve their sleep and overall health.12345Why are researchers excited about this trial?
Researchers are excited about Cognitive Behavioral Therapy for Insomnia (CBT-I) in people with Type 2 Diabetes because it offers a non-drug approach to tackle sleep issues, unlike traditional treatments like sleep medications. CBT-I focuses on changing the thoughts and behaviors that cause insomnia, which can lead to long-lasting improvement in sleep quality without the side effects associated with medication. Additionally, improving sleep in Type 2 Diabetes patients can have a positive impact on blood sugar control and overall health, making it a promising holistic option.
What evidence suggests that Cognitive Behavioral Therapy for Insomnia might be an effective treatment for insomnia in type 2 diabetes?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I), which participants in this trial may receive, can assist people with type 2 diabetes who struggle with sleep. Studies have found that CBT-I not only improves sleep quality but also aids in controlling blood sugar levels. For instance, one study found that CBT-I helped lower HbA1c levels, a measure of blood sugar over time. Another study noted improvements in sleep problems and mood, which can also aid in managing diabetes. Overall, CBT-I is considered a promising method to enhance both sleep and diabetes management.12346
Are You a Good Fit for This Trial?
This trial is for adults over 40 with uncontrolled type 2 diabetes (HbA1c >7%) and chronic insomnia (Insomnia Severity Index score ≥15). It's specifically designed for patients in Louisiana, aiming to address sleep disturbances that affect diabetes management. Participants must be able to attend an 8-week program at a federally qualified health center.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an 8-week Cognitive Behavioral Therapy for Insomnia (CBT-I) program
Follow-up
Participants are monitored for sleep and cardiometabolic outcomes post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy for Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor